Bioavailability and transport of peptides and peptide drugs into the brain

Peptides

Volumn 18, Issue 9, 1997, Pages 1431-1439

  Egleton, Richard D ^a   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Peptides; Transport systems

Indexed keywords

PEPTIDE HORMONE;

AMINO ACID SEQUENCE; BIOAVAILABILITY; BLOOD BRAIN BARRIER; ENDOTHELIUM CELL; GENE TARGETING; METABOLIC ACTIVATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STABILITY; REVIEW; TARGET CELL; TRANSPORT KINETICS;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; PEPTIDES;

EID: 0030726198     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00242-8     Document Type: Review

References (85)

1. Abbott N. J., Revest P. A., Romero I. A. Astrocyte-endothelial interaction physiology and pathology . Neuropathol. Applied Neurobiol. 18:1992;424-433.
2. Abbruscato T. J., Thomas S. A., Hruby V. J., Davis T. P. Blood-brain barrier permeability and bioavailability of a highly potent and μ-selective opioid receptor antagonist, CTAP comparison with morphine . J. Pharm. Exp. Ther. 280:1997;402-409.
3. Abbruscato T. J., Thomas S. A., Hruby V. J., Davis T. P. Brain and spinal cord distribution of biphalin Correlation with opioid receptor density and mechanism of CNS entry . 1997;in press, J. Neurochem. 69.
4. Abbruscato T. J., Williams S. A., Misicka A., Lipkowski A. W., Hruby V. J., Davis T. P. Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives. J. Pharm. Exp. Ther. 276:1996;1049-1057.
5. Arthur F. E., Shivers R. R., Bowman P. D. Astrocyte-mediated induction of tight junctions in brain capillary endothelium an efficient in vitro model . Dev. Brain Res. 36:1987;155-159.
6. Audus K. L., Borchardt R. T. Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharmaceutical Res. 3:1986;81-87.
7. Audus, K. L.; Chikale, P. I.; Miller, D. W.; Thompson, S. E.; Borchardt, R. T. Brain uptake of drugs: The influence of chemical and biological factors. In: Testa, B. ed. Advances in drug research 23. Academic Press London, 1992.
8. Banks W. A., Kastin A. J. A brain-to-blood carrier-mediated transport system for small N-tyrosinated peptides. Pharmacol. Biochem. Behav. 21:1984;943-946.
9. Banks W. A., Kastin A. J. Aluminum increases permeability of the blood-brain barrier to labeled DSIP and β-endorphin possible implications for senile and dialysis dementia . Lancet. II:1983;1227-1229.
10. Banks W. A., Kastin A. J. Leucine modulates peptide transport system-1 across the blood-brain barrier at the stereospecific site within the central nervous system. J. Pharm. Pharmacol. 43:1991;252-254.
11. Banks W. A., Kastin A. J. The role of the blood-brain barrier transporter PTS-1 in regulating concentrations of methionine enkephalin in blood and brain. Alcohol. 14:1997;237-245.
12. Banks W. A., Kastin A. J., Akerstrom V., Jaspan J. B. Radioactively iodinated cyclo (His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis. Am. J. Physiol. 264:1993;E723-E729.
13. Banks W. A., Kastin A. J., Ehrensing C. A. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from brain to the blood by peptide transport system-1. J. Neurosci. Res. 35:1993;690-695.
14. Banks W. A., Kastin A. J., Harrison L. M., Zadina J. E. Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1. Neurotoxicol. Teratol. 18:1996;711-715.
15. Banks W. A., Kastin A. J., Michaels E. A., Barrera C. M. Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1. Brain Res. Bull. 25:1990;589-592.
16. Banks W. A., Kastin A. J., Sam H. M., Cao V. T., King B., Maness L. M., Schally A. V. Saturable efflux of the peptides RC-160 and Tyr-MIF-1 by different parts of the blood-brain barrier. Brain Res. Bull. 2:1994;179-182.
17. Banks W. A., Schally A. V., Barrera C. M., Fasold M. B., Durham D. A., Csernus V. J., Groot K., Kastin A. J. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. USA. 87:1990;6762-6766.
18. 8-13 analog NT1. Brain Res. 695:1995;59-63.
19. Beck D. W., Roberts R. L. ; Olson. Glial cells influence membrane associated enzyme activity at the blood-brain barrier. Brain Res. 381:1986;131-137.
20. Begley D. J., Lechardeur D., Chen Z. D., Rollinson C., Bardoul M., Roux F., Scherman D., Abbott N. J. Functional expression of P-glycoprotein in an immortalized cell line of rat brain endothelial cells, RBE4. J. Neurochem. 67:1996;988-995.
21. Betz A. L., Csejtey J., Goldstein G. W. Hexose transport and phosphorylation by capillaries isolated from rat brain. Amer. J. Physiol. 236:1979;C96-C102.
22. Betz A. L., Goldstein G. W. Polarity of the blood brain barrier neutral amino acid transport into isolated brain capillaries . Science. 202:1978;225-227.
23. Bickel U., Kang Y. S., Pardridge W. M. In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brain. Bioconjug. Chem. 6:1995;211-218.
24. Borison H. L., Wang S. C. Physiology and pharmacology of vomiting. Pharmacol. Rev. 5:1953;193-230.
25. Brewster M. E., Estes K. S., Perchalski R., Bodor N. A dihydropyridine conjugate which generates high and sustained levels of corresponding pyridinium salt in the brain does not exhibit neurotoxicity in cynomolugus monkeys. Neurosci. Lett. 87:1988;277-282.
26. Brightman, M. Ultrastructure of brain endothelium. In: Bradbury, M. W. B. (Ed) Physiology and pharmacology of the blood-brain barrier. Handbook of experimental pharmacology 103, Springer-Verlag Berlin 1-22, 1992.
27. Brightman M. W., Reese T. S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40:1969;648-677.
28. Brownlees J., Williams C. H. Peptidases, peptides at the mammalian blood-brain barrier. J. Neurochem. 60:1993;793-803.
29. Brownson E. A., Abbruscato T. J., Gillespie T. J., Hruby V. J., Davis T. P. Effect of peptidases at the blood-brain barrier on the permeability of enkephalin. J. Pharm. Exp. Ther. 270:1994;675-680.
30. Butt A. M., Jones H. C., Abbott N. J. Electrical resistance across the blood-brain barrier in anaesthetized rats A developmental study . J. Physiol (London). 429:1990;47-62.
31. + requiring system for alanine, serine, cysteine and similar amino acids. J. Biol. Chem. 242:1967;5237-5246.
32. Ciechanover A., Schwartz A. L., Dautry-Varsat A., Lodish H. F. Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J. Biol. Chem. 258:1983;9681-9689.
33. Crone C., Cristensen O. Electrical resistance of a capillary endothelium. J. Gen. Physiol. 77:1981;349-371.
34. Crone C., Olesen S. P. ; Electrical resistance of brain microvascular endothelium. Brain Res. 241:1982;49-55.
35. Davson, H.; Segal, M. B. Morphological barriers of the barriers. In: Davson, H.; Segal, M. B. eds. Physiology of the CSF and blood-brain barriers. CRC Press; 1995:93-192.
36. Davson, H.; Segal, M. B. Physiology of the CSF and blood-brain barriers. CRC Press, 1995:1-10.
37. Dehouck M. P., Meresse S., Delorme P., Fruchart J. C., Cecchelli R. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J. Neurochem. 54:1990;1798-1801.
38. Diamond J. M., Wright E. M. Molecular forces governing non-electrolyte permeation through cell membranes. Proc. Royal. Soc. 172:1969;273-316.
39. Drion N., Lemaire N., Lefauconnier J.-M., Schermann J.-M. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. J. Neurochem. 67:1996;1688-1693.
40. 3H] methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sci. 21:1977;907-914.
41. Durham D. A., Banks W. A., Kastin A. J. Carrier-mediated transport of oxytocin from brain to blood. Neuroendocrinology. 53:1991;447-452.
42. Fishman J. B., Rubin J. B., Handrahan J. V., Connor J. R., Fine R. E. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J. Neurosci. Res. 18:1987;299-304.
43. Golden P. L., Maccagnan T. J., Pardridge W. M. Human blood-brain barrier receptor binding and endocytosis in isolated human brain microvessels . J. Clin. Invest. 99:1997;14-18.
44. Greene D. L., Hau V. S., Abbruscato T. J., Bartosz H., Misicka A., Lipkowski A. W., Hom S., Gillespie T. J., Hruby V. J., Davis T. P. Enkephalin analog prodrugs assessment of an in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability . J. Pharm. Exp. Ther. 277:1996;1366-1375.
45. Grieg N. Drug entry into the brain and its pharmacologic manipulation. Bradbury M. W. B. Physiology and pharmacology of the blood-brain barrier Handbook of experimental pharmacology 103 . 1992;487-523 Springer-Verlag, Berlin.
46. Guillot F. L., Audus K. L., Raub T. Fluid-phase endocytosis by primary cultures of bovine brain microvessel endothelial cell monolayers. Microvascular Res. 39:1990;1-14.
47. Horan P. J., Mattia A., Bilsky E. J., Weber S., Davis T. P. , Yamamura, H. I.; Malatynska, E.; Appelyard, S. M.; Slaninova, J.; Misicka, A.; Lipkowski, A. J.; Hruby, V. J.; Porreca, F. Antinociceptive profile of biphalin, a dimeric enkephalin analog. J. Pharm. Exp. Ther. 265:1993;1446-1454.
48. Jefferies W. A., Brandon M. R., Hunt S. V., Williams A. F., Mason D. Y. Transferrin receptor on endothelium of brain capillaries. Nature. 312:1984;162-163.
49. Kramer T. H., Shook J. E., Kazmierski W., Ayers E. A., Wire W. S., Hruby V. J., Burks T. F. Novel peptidic mu opioid antagonists pharmacologic characterization in vitro and in vivo . J. Pharmacol. Exp. Ther. 249:1989;544-549.
50. Kreuter J., Alyautdin R. N., Kharkevich D. A., Ivanov A. A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674:1995;171-174.
51. Kumagi A. K., Eisenberg J. B., Pardridge W. M. Adsorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain microvessels. J. Biol. Chem. 262:1987;15214-15219.
52. Lee, H. J. Biopharmaceutical properties and pharmacokinetics of peptide and protein drugs. In: Taylor, M. D.; Amidon, G. L. (eds.). Peptide-based drug design: Controlling transport and metabolism. American Chemical Society Washington DC. 1995:69-100.
53. Maxwell K., Berliner J. A., Cancill P. A. Induction of gamma-glutamyl transpeptidase in cultured cerebral endothelial cells by a product released by astrocytes. Brain Res. 410:1987;309-314.
54. Mosberg H. I., Hurst R., Hruby V. J., Gee K., Yamamura H. I., Galligan J. J., Burks T. F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. 80:1983;5871-5874.
55. Oldendorf W. H. Lipid solubility and drug penetration of the blood-brain barrier. Proc. Soc. Exp. Biol. Med. 147:1974;813-816.
56. Oldendorf W. H., Szabo J. Amino acid assignment to one of three blood-brain barrier acid carriers. Am. J. Physiol. 230:1976;94-98.
57. Olesen S. P., Crone C. Electrical resistance of muscle capillary endothelium. Biophys. J. 42:1983;31-41.
58. Ooi G. T. Insulin-like growth factor-binding proteins (IGFBPs) more than just 1, 2, 3 . Mol. Cell. Endocrinol. 71:1990;C39-C43.
59. Pardridge W. M., Mietus L. J. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin bound hormone. J. Clin. Invest. 64:1979;145-154.
60. Pardridge W. M., Triguero D., Yang J. P. A. Comparisons of in vitro and in vivo models of transcytosis through the blood-brain barrier. J. Pharm. Exp. Ther. 253:1990;884-891.
61. Plotkin S. R., Banks W. A., Waguespack P. J., Kastin A. J. Ethanol alters the concentration of Met-Enkephalin in brain by affecting peptide transport system-1 independent of preproenkephalin mRNA. J. Neurosci. Res. 48:1997;273-280.
62. 14C mannitol using the rat in situ brain perfusion technique. Dev. Brain Res. 87:1995;69-76.
63. Raub T. J., Audus K. L. Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers. J. Cell Sci. 97:1990;127-138.
64. Reese T. S., Karnovsky M. J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 43:1967;207-217.
65. Roux F. S., Durieu-Trautman O., Chaverot N., Claire M., Maily P., Bourre J.-M., Strosberg A. D., Couraud P.-O. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvascular endothelial cells. J. Cell. Physiol. 159:1994;101-113.
66. Rubin L. L., Hall D. E., Porter S., Barbu K., Cannon C., Horner H. C., Janatapour M., Liaw C. W., Manning K., Morales J., Tanner L. I., Tomaselli K. J., Bard F. A cell culture model of the blood-brain barrier. J. Cell Biol. 115:1991;1725-1735.
67. Siakatos A. N., Rouser G., Fleischer S. Isolation of highly perified human and bovine endothelial cell and nuclei and their phospholipid composition. Lipids. 4:1969;234-239.
68. Stanimirovic D., Morley P., Ball R, Hamel E., Mealing G., Durkin J. P. Angiotensin II-induced fluid phase endocytosis in human cerebromicrovascular endothelial cells is regulated by the inositol-phosphate signaling pathway. J. Cell Physiol. 169:1996;455-467.
69. Sussman I., Carson M. P., McCall A. L. ; Schultz. V.; Ruderman, N. M.; Tornheim. Energy state of bovine cerebral microvessels of isolation methods. Microvasc. Res. 35:1988;167-178.
70. Tamai I., Sai Y., Koayashi H., Kamata M. ; Wakamiya, T; Tsuji, A. Structure- internalization relationship for adsorptive-mediated endocytosis of basic peptides at the blood-brain barrier. J. Pharm. Exp. Ther. 280:1997;410-415.
71. Tao-Cheng J. H., Nagy Z., Brightman M. W. Tight junctions of brain endothelium in vitro are enhanced by astroglia. J. Neurosci. 7:1987;3293-3299.
72. Thomas S. A., Abbruscato T. J., Hau V. S., Gillespie T. J., Zsigo J., Hruby V. J., Davis T. P. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain permeability and stability. J. Pharm. Exp. Ther. 281:1997;817-825.
73. Thomas S. A., Abbruscato T. J., Hruby V. J., Davis T. P. The entry of [D-penicillamine2, 5]enkephalin into the central nervous system saturation kinetics and specificity . J. Pharm. Exp. Ther. 280:1997;1235-1240.
74. Voetmann, E. On the structure and surface area of the human choroid plexus. Acta Anatomica (Suppl) 10; 1949.
75. Wade L. A., Katzman R. Synthetic amino acids and the nature of the L-DOPA transport at the blood-brain barrier. J. Neurochem. 25:1975;837-842.
76. 5]enkephalin and two halogenated analogs after intravenous administration. J. Pharm. Exp. Ther. 259:1991;1109-1117.
77. Weber S. J., Abbruscato T. J., Brownson E. A., Lipkowski A. W., Polt P., Misicka A., Haaseth R. C., Bartosz H., Hruby V. J., Davis T. P. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs. J. Pharm. Exp. Ther. 266:1993;1649-1655.
78. 5]enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration. J. Pharm. Exp. Ther. 263:1992;1308-1316.
79. Williams S. A., Abbruscato T. J., Hruby V. J., Davis T. P. Passage of a δ-opioid receptor selective enkephalin [D-penicillamine2, 5]enkephalin, across the blood-brain and blood-cerebrospinal fluid barriers. J. Neurochem. 66:1996;1289-1299.
80. Wu-Wong J. R., Chiou W. J., Hoffman D. J., Winn M., von Geldern T. W., Opgenorth T. J. Endothelins and endothelin receptor antagonists binding to plasma proteins . Life Sci. 58:1996;1839-1847.
81. Zapf J., Kiefer M., Merryweather J., Masiarz F., Bauer D., Born W., Fischer J. A., Froesch E. R. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF 1 administration and in extrapancreatic tumor hypoglycemia. J. Biol. Chem. 265:1990;14892-14898.
82. Zlokovic B. V., Banks W. A., el Kadi H., Erchegyi J., Mackic J. B., McComb J. G., Kastin A. J. Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier. Brain Res. 590:1992;213-218.
83. Zlokovic B. V., Hyman S., McComb J. G., Lipovac M. N., Tang G., Davson H. Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochimica et Biophysica Acta. 1025:1990;191-198.
84. Zlokovic, B. V.; Mackic, J. B.; Djuricic, B.; Davson, H. Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J. Neurochem. 1333-1340; 1989.
85. Zlokovic B. V., Susic V. T., Davson H., Begley D. J., Jankov R. M., Mitovic D. M., Lipovac M. N. Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain. Peptides. 10:1989;249-254.